Evaluation of mailing for HPV testing

SHARE
INVITRO-NEWs-REVISTA-EN-SALUD-CANCER-DE-CUELLO-UTERINO-vph

Evaluation of the impact of postal delivery of self-sampling kits for human papillomavirus testing to unscreened, non-responder to unresponsive, unscreened women in Manitoba.

Casa Comercial Asociada: Copan


Keywords: Human papillomavirus, DNA testing, cervical cancer, cancer screening.

 

The present study illustrates that mailing self-sampling kits for HPV screening is a viable option for women, in most cases, at risk of developing cervical cancer and supports the growing evidence and trend to move from Pap testing to HPV testing for cervical cancer screening.

The HPV self-sampling device used in the study was the FLOQSwab (Copan Diagnostics, Murrieta, CA, USA).


More information:

https://mediadelivery.copangroup.com/wp-content/uploads/2021/06/Booklet-Self-Collection.pdf

Most viewed

Multiple myeloma in Colombia, its impact and the need for timely diagnosis.

More profitable laboratory: automation in sample receipt

First Neonatal Screening Project In Colombia

Significance of ART vs. CD4 ratio